Lanza, Gregory M.

Molecular Imaging of Angiogenesis in Early-Stage Atherosclerosis With α v β 3 -Integrin–Targeted Nanoparticles

Winter, P. M., Morawski, A. M., Caruthers, S. D., Fuhrhop, R. W., Zhang, H., Williams, T. A., Allen, J. S., Lacy, E. K., Robertson, J. D., Lanza, G. M., et al. (2003) · Circulation

Cardiac Imaging and DiagnosticsAtherosclerosis and Cardiovascular Diseases

Cited by 696

Novel MRI Contrast Agent for Molecular Imaging of Fibrin: Implications for Detecting Vulnerable Plaques

Flacke, S., Fischer, S., Scott, M. J., Fuhrhop, R. J., Allen, J. S., McLean, M., Winter, P., Sicard, G. A., Gaffney, P. J., Wickline, S. A., et al. (2001) · Circulation

Lanthanide and Transition Metal ComplexesAdvanced MRI Techniques and Applications

Cited by 515

A Novel Site-Targeted Ultrasonic Contrast Agent With Broad Biomedical Application

Lanza, G. M., Wallace, K. D., Scott, M. J., Cacheris, W. P., Abendschein, D. R., Christy, D. H., Sharkey, A. M., Miller, J. G., Gaffney, P. J., & Wickline, S. A. (1996) · Circulation

Ultrasound and Hyperthermia ApplicationsPhotoacoustic and Ultrasonic Imaging

Cited by 406

Endothelial α ν β 3 Integrin–Targeted Fumagillin Nanoparticles Inhibit Angiogenesis in Atherosclerosis

Winter, P. M., Neubauer, A. M., Caruthers, S. D., Harris, T. D., Robertson, J. D., Williams, T. A., Schmieder, A. H., Hu, G., Allen, J. S., Lacy, E. K., et al. (2006) · Arteriosclerosis, Thrombosis, and Vascular Biology

Nanoparticle-Based Drug DeliveryAtherosclerosis and Cardiovascular Diseases

Cited by 379

Computed Tomography in Color: NanoK‐Enhanced Spectral CT Molecular Imaging

Pan, D., Roessl, E., Schlomka, J., Caruthers, S. D., Senpan, A., Scott, M. J., Allen, J. S., Zhang, H., Hu, G., Gaffney, P. J., et al. (2010) · Angewandte Chemie International Edition

Cardiac Imaging and DiagnosticsAdvanced X-ray and CT Imaging

Cited by 178

Antiangiogenic Synergism of Integrin-Targeted Fumagillin Nanoparticles and Atorvastatin in Atherosclerosis

Winter, P. M., Caruthers, S. D., Zhang, H., Williams, T. A., Wickline, S. A., & Lanza, G. M. (2008) · JACC: Cardiovascular Imaging

Nanoparticle-Based Drug DeliveryAtherosclerosis and Cardiovascular Diseases

Cited by 166

Rapamycin nanoparticles target defective autophagy in muscular dystrophy to enhance both strength and cardiac function

Bibee, K. P., Cheng, Y., Ching, J. K., Marsh, J. N., Li, A. J., Keeling, R. M., Connolly, A. M., Golumbek, P. T., Myerson, J. W., Hu, G., et al. (2014) · The FASEB Journal

Muscle Physiology and DisordersAutophagy in Disease and Therapy

Cited by 83